Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 880 results for "astrazeneca"

AgPlus Diagnostics to develop point-of-care test for AstraZeneca
Business Weekly UK

AgPlus Diagnostics to develop point-of-care test for AstraZeneca

AgPlus Diagnostics in Sharnbrook, Bedfordshire, is to develop a prototype diagnostic assay for UK pharma giant AstraZeneca for potential use as part of a personalised approach to treating respiratory disease. AgPlus platform technology combines ... Business Weekly UK, 6 hours ago
Development of a Manufacturing Route to Avibactam, a β-Lactamase Inhibitor Organic Process Research & Development, 7 hours ago
AstraZeneca and Microsoft to develop new drug technology for cancer Drug Development Technology, 4 days ago
[x]  

989 images for astrazeneca

Ticker Report, 23 hours ago
American Banking News, 4 days ago
Motley Fool UK, 4 days ago
Octafinance, 4 days ago
Octafinance, 4 days ago
Yahoo! Singapore, 6 days ago
Reuters India, 6 days ago
Octafinance, 6 days ago
Cleanroom Technology, 10 hours ago
Business Weekly UK, 3 hours ago
BioPharma Dive

Whose Drug Pipeline Impresses Most? A Rough Comparison Of GlaxoSmithKline And AstraZeneca

Back in May, I proposed a simple method for roughly assessing the value of a pharma company's drug research pipeline . Put simply it involves working out the revenue replacement value of each of their Phase III trials. Phase III trials are ...
 Seeking Alpha1 day ago AstraZeneca drops EMA application for cancer drug  BioPharma Dive5 days ago AstraZeneca pulls EU cancer drug application  Pharma Live6 days ago AstraZeneca pulls cancer drug application in Europe  London South East6 days ago
[x]  
Motley Fool UK

Is this a better healthcare buy than AstraZeneca plc after today's update?

One of the UK's leading providers of veterinary services CVS Group (LSE: CVS) has released a set of upbeat full-year results that suggest now could bethe right time to buy it. But is it a superior buy to healthcare sector peer AstraZeneca (LSE: ...
 Yahoo! Finance UK and Ireland4 days ago
Investor's Business Daily

Regeneron-Sanofi Could Beat Pfizer, Roche, AstraZeneca On Eczema

The FDA could approve a breakthrough adult eczema treatment from Regeneron and Sanofi as soon
 BioSpace1 day ago AstraZeneca PLC Yanks Ovarian Cancer EU Application After 'Differences Of Opinion' With Regulators  BioSpace5 days ago AstraZeneca Withdraws EU Application for Ovarian-Cancer Therapy  Bloomberg6 days ago AstraZeneca Withdraws Application For EU Approval For Ovarian-Cancer Medicine  Fat Pitch Financials6 days ago
[x]  

AstraZeneca Agrees to Pay $5.5 Million to Settle FCPA Charges with SEC

On August 30, the SEC announced a $5.5 million settlement with AstraZeneca, the U.K.-based pharmaceutical company, to settle charges under the FCPA's books and records and internal control provisions due to allegedly improper payments made by the ...
 Lexology6 days ago
Yahoo! Finance UK and Ireland

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

Do hares always beat tortoises? Are speedboats better than ocean liners? Are small-cap startup companies better than the established giants for growing your investment cash? A lucrative startup? The question must have crossed a few minds when ...
 Yahoo! Finance UK and Ireland1 week ago
Nasdaq

ASTRAZENECA : Diabetes drug combo shows positive results in late-stage study

AstraZeneca reported that a late-stage trial came up with positive results in reducing blood sugar for those with diabetes that was not controlled by other means. Results from the Phase 3 trial indicated that a once-a-week injected dose of Bydureon ...
 4 Traders5 days ago AstraZeneca diabetes drug combination meets main goals in Phase III study  Pharmaceutical Business Review1 week ago AstraZeneca reports positive Phase III data for Farxiga, Bydureon combination in type 2 diabetes  FirstWord Pharma1 week ago
[x]  
Ely News

Diabetes breakthrough from AstraZeneca could help weight loss

Comments(0) AstraZeneca has announced a big breakthrough for people suffering from type-two diabetes which will also help them to lose weight. Late stage clinical trials have shown that Duration-8, which is Bydureon, taken just once a week in ...
 Ely News1 week ago AstraZeneca up after diabetes combo passes phase III  Proactive Investors.co.uk1 week ago
First Post.com

This stock tanked 11% in an otherwise dull market

AstraZeneca Pharma stock plunged almost 11 per cent in trade on Thursday as it will stop selling anti-bacterial drug Meronem in India following a global deal by its UK parent to sell its small molecule antibiotics business to Pfizer Inc. The scrip tanked 7.93 ...
 Money Today1 month ago Top buzzing midcap stocks to trade on August 25  Money Control1 month ago AstraZeneca tanks almost 11% on termination notice for Meronem  Money Control1 month ago Pfizer to purchase antibiotics business of AstraZeneca  Business Standard1 month ago
[x]  

Glenmark receives US FDA approval for skin ointment lidocaine

The approved product is the generic version of AstraZeneca's Xylocaine ointment (5%), which recorded annual sales of approximately $ 373 million BS B2B Bureau | Mumbai September 12, 2016 Last Updated at 14:01 IST The US Food & Drug Administration (FDA) has ...
 Business Standard2 weeks ago Glenmark gets USFDA nod for Xylocaine ointment  Business Standard2 weeks ago Glenmark Pharma receives ANDA approval for Lidocaine Ointment USP, 5%  Money Control2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - astrazeneca
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less